Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells

[1]  Xiao Wang,et al.  Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of β cell identity genes , 2022, Cell death & disease.

[2]  M. Qiao,et al.  Butyrate Protects Pancreatic Beta Cells from Cytokine-Induced Dysfunction , 2021, International journal of molecular sciences.

[3]  Yulong Yin,et al.  Butyrate in Energy Metabolism: There Is Still More to Learn , 2021, Trends in Endocrinology & Metabolism.

[4]  M. Lorincz,et al.  Transcription shapes genome-wide histone acetylation patterns , 2021, Nature Communications.

[5]  E. Kostenis,et al.  FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells , 2020, Scientific Reports.

[6]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[7]  Annika Lundqvist,et al.  The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. , 2020, Cell metabolism.

[8]  J. Weitz,et al.  Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis. , 2020, Cell reports.

[9]  P. de Vos,et al.  Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under Oxidative Stress , 2020, International journal of molecular sciences.

[10]  N. Billestrup,et al.  Beta-cell dysfunction induced by non-cytotoxic concentrations of Interleukin-1β is associated with changes in expression of beta-cell maturity genes and associated histone modifications , 2019, Molecular and Cellular Endocrinology.

[11]  M. Gannon,et al.  The Beta Cell in Type 2 Diabetes , 2019, Current Diabetes Reports.

[12]  Wen-Jeng Wu,et al.  Epigenetic regulation of COX-2 expression by DNA hypomethylation via NF-κB activation in ketamine-induced ulcerative cystitis , 2019, International journal of molecular medicine.

[13]  S. Han,et al.  Short-chain Fatty Acids Inhibit Staphylococcal Lipoprotein-induced Nitric Oxide Production in Murine Macrophages , 2019, Immune network.

[14]  Jingyuan Fu,et al.  Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases , 2019, Nature Genetics.

[15]  R. Gómez,et al.  Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor , 2018, Cellular Physiology and Biochemistry.

[16]  Jing Chen,et al.  Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress. , 2018, Environmental toxicology and pharmacology.

[17]  Chenlin Gao,et al.  Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice. , 2018, The Journal of endocrinology.

[18]  Matthew V. Holt,et al.  Early butyrate induced acetylation of histone H4 is proteoform specific and linked to methylation state , 2018, Epigenetics.

[19]  T. R. Licht,et al.  Aberrant intestinal microbiota in individuals with prediabetes , 2018, Diabetologia.

[20]  B. Wagner,et al.  Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes , 2017, The Journal of Biological Chemistry.

[21]  M. Donath,et al.  The Role of Inflammation in β-cell Dedifferentiation , 2017, Scientific Reports.

[22]  T. Sparer,et al.  Pancreatic islet inflammation: an emerging role for chemokines. , 2017, Journal of molecular endocrinology.

[23]  M. Zwinderman,et al.  Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation. , 2016, Current opinion in chemical biology.

[24]  T. Umehara,et al.  Histone H4 lysine 20 acetylation is associated with gene repression in human cells , 2016, Scientific Reports.

[25]  Danhong Lu,et al.  IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB. , 2015, American journal of physiology. Endocrinology and metabolism.

[26]  G. Jena,et al.  Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. , 2014, Chemico-biological interactions.

[27]  S. Ghosh,et al.  Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes , 2014, Front. Immunol..

[28]  Danhong Lu,et al.  NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription. , 2014, American journal of physiology. Endocrinology and metabolism.

[29]  C. Workman,et al.  Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection , 2014, Proceedings of the National Academy of Sciences.

[30]  D. Hallinger,et al.  Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes , 2014, Diabetologia.

[31]  M. Kleerebezem,et al.  Modulation of the microbial fermentation in the gut by fermentable carbohydrates , 2013 .

[32]  Danhong Lu,et al.  Regulation of iNOS gene transcription by IL-1β and IFN-γ requires a coactivator exchange mechanism. , 2013, Molecular endocrinology.

[33]  Ming-qing Li,et al.  Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity. , 2013, International journal of clinical and experimental pathology.

[34]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[35]  M. Schmitz,et al.  The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB , 2012, Nucleic acids research.

[36]  I. Lundquist,et al.  Pancreatic β‐cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes , 2012, Diabetes, obesity & metabolism.

[37]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[38]  N. Morgan,et al.  Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children , 2012, Diabetologia.

[39]  Chunliu Yang,et al.  Short-Chain Fatty Acids Suppress Lipopolysaccharide-Induced Production of Nitric Oxide and Proinflammatory Cytokines Through Inhibition of NF-κB Pathway in RAW264.7 Cells , 2012, Inflammation.

[40]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[41]  P. Halban,et al.  Cytokine production by islets in health and diabetes: cellular origin, regulation and function , 2010, Trends in Endocrinology & Metabolism.

[42]  H. Ellingsgaard,et al.  Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. , 2009, Physiology.

[43]  P. Woster,et al.  A novel histone deacetylase inhibitor prevents IL‐1β induced metabolic dysfunction in pancreatic β‐cells , 2009, Journal of cellular and molecular medicine.

[44]  N. Morgan,et al.  Islet-associated macrophages in type 2 diabetes , 2009, Diabetologia.

[45]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[46]  H. Afif,et al.  Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. , 2008, Osteoarthritis and cartilage.

[47]  A. Burny,et al.  A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. , 2008, Trends in biochemical sciences.

[48]  R. Mahato,et al.  iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis. , 2008, Molecular pharmaceutics.

[49]  M. V. Suresh,et al.  Regulatory roles for histone deacetylation in IL-1β-induced nitric oxide release in pancreatic β-cells , 2007, Journal of cellular and molecular medicine.

[50]  H. Ellingsgaard,et al.  Increased Number of Islet-Associated Macrophages in Type 2 Diabetes , 2007, Diabetes.

[51]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[52]  E. Seidman,et al.  Dual effect of butyrate on IL-1beta--mediated intestinal epithelial cell inflammatory response. , 2007, DNA and cell biology.

[53]  N. Sang,et al.  Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. , 2007, Cancer research.

[54]  Hee-Sun Kim,et al.  Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells : Involvement of NF-κB and ERK signaling pathways , 2007 .

[55]  S. G. Rønn,et al.  Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells , 2007, Diabetologia.

[56]  Zhi-yuan Yu,et al.  Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. , 2006, American journal of physiology. Renal physiology.

[57]  D. Eizirik,et al.  Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor κB-mediated gene expression in insulin-producing INS-1E cells , 2005, Diabetologia.

[58]  R. Place,et al.  HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα , 2005 .

[59]  A. Pautz,et al.  Regulation of the expression of inducible nitric oxide synthase. , 2004, European journal of pharmacology.

[60]  C. Van Lint,et al.  Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. , 2004, Biochemical pharmacology.

[61]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids , 2004, British journal of pharmacology.

[62]  A. Burny,et al.  Potentiation of Tumor Necrosis Factor-Induced NF-κB Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of IκBα , 2003, Molecular and Cellular Biology.

[63]  T. Menzel,et al.  Butyrate Inhibits Interleukin-1-Mediated Nuclear Factor-Kappa B Activation in Human Epithelial Cells , 2001, Digestive Diseases and Sciences.

[64]  Mogens Kruhøffer,et al.  Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. , 2003, Diabetes.

[65]  J. Davie.  Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[66]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[67]  C. Sardet,et al.  Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.

[68]  W. Greene,et al.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.

[69]  Wenzheng Zhang,et al.  Histone deacetylases augment cytokine induction of the iNOS gene. , 2002, Journal of the American Society of Nephrology : JASN.

[70]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[71]  P. Becker,et al.  Histone acetylation: a switch between repressive and permissive chromatin , 2002, EMBO reports.

[72]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[73]  M. M. Mu,et al.  The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. , 2001 .

[74]  L. Yin,et al.  Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity* , 2001, The Journal of Biological Chemistry.

[75]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[76]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[77]  M. Tyers,et al.  Duration of Nuclear NF-kB Action Regulated by Reversible Acetylation , 2001 .

[78]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[79]  G. Spinas.  The Dual Role of Nitric Oxide in Islet β-Cells , 1999 .

[80]  D. Eizirik,et al.  Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells , 1998, Diabetologia.

[81]  M. Su,et al.  Interleukin-1β-induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein Kinases* , 1998, The Journal of Biological Chemistry.

[82]  G. Panagiotidis,et al.  Interaction of the islet nitric oxide system with L‐arginine‐induced secretion of insulin and glucagon in mice , 1996, British journal of pharmacology.

[83]  M. Mcdaniel,et al.  Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. , 1995, Endocrinology.

[84]  D. Eizirik,et al.  Studies on the molecular regulation of the inducible form of nitric oxide synthase (iNOS) in insulin-producing cells , 1994, Molecular and Cellular Endocrinology.

[85]  M. Mcdaniel,et al.  Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. , 1994, The Biochemical journal.

[86]  N. Welsh,et al.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.

[87]  M. Mcdaniel,et al.  Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Mcdaniel,et al.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. , 1992, The Journal of clinical investigation.

[89]  M. Mcdaniel,et al.  Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. , 1991, The Journal of biological chemistry.

[90]  I. Green,et al.  Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism , 1990 .

[91]  Norma Banas,et al.  Virtual Reality Visualization of 3-D Electromagnetic Fields , 2000 .